Bill Gross successor at Janus Henderson to quit at 44 and hit the road with kids financial-planning.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financial-planning.com Daily Mail and Mail on Sunday newspapers.
May 14 2021, 6:09 AM
May 11 2021, 4:30 AM
May 14 2021, 6:09 AM
(Bloomberg) Chinese debt is back in favor with overseas investors.
(Bloomberg) Chinese debt is back in favor with overseas investors.
After the nationâs government bonds suffered their first outflow in two years in March, foreigners added 52 billion yuan ($8.1 billion) to their holdings in April, bringing the total to a record 2.1 trillion yuan, data compiled by ChinaBond show.
In a game-changing shift compared by some to the birth of the euro yuan-denominated debt has emerged as a refuge during this yearâs global bond rout. Investors looking for diversification have piled in, seeking its relatively high yields and low correlation to other markets. While that partially reversed in March, as rising U.S. yields dimmed Chinese bondsâ appeal, the quick turnaround has underscored the resilience of demand and Chinaâs growing clout since opening its fixed-income market.
Nuvalent, Inc., a Cambridge, Mass.-based biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, closed a $135m Series B financing.
The round was led by Bain Capital Life Sciences with participation from sole founding investor, Deerfield Management, and additional new investors Fidelity Management and Research Company LLC, Wellington Management Company, Viking Global Investors, Janus Henderson Investors, Avoro Capital Advisors, Boxer Capital of Tavistock Group, Venrock Healthcare Capital Partners, Fairmount Funds Management LLC, Driehaus Capital Management LLC, and Logos Capital. In conjunction with the funding, Andrew Hack, M.D., Ph.D., a Managing Director of Bain Capital Life Sciences, will join the Nuvalent Board of Directors.
Singapore s stellar stock run stalls as virus cases jump yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
SINGAPORE (BLOOMBERG) - A rally in one of Asia’s best-performing stock markets is stalling amid rising virus cases at home and a rethink of the global reflation trade.
Second only to Taiwan among Asia’s major benchmarks this year, Singapore’s Straits Times Index (STI) has slipped 1 per cent so far in May, paring 2021’s gains to about 12 per cent. The reintroduction of social distancing rules following the emergence of new clusters has weighed on investor sentiment, despite the country having one of the highest vaccine coverage in Asia.
But this isn’t only a Singapore story. The Asian financial hub is a microcosm of the worldwide economic rebound, with exports standing at more than 150 per cent of gross domestic product. And with an Asia-leading 86 per cent weighting in so-called cyclicals, the STI has stuttered alongside a pause in the global rotation to such economically-sensitive shares.